Lini Pandite

Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

David Planchard, Tae Min Kim, Julien Mazières et al. · The Lancet Oncology · 2016 · 444 citations · Full text

Medicine, Oncology, Pharmacology +8

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma

Sandra P. D’Angelo, Luca Melchiori, Melinda S. Merchant et al. · Cancer Discovery · 2018 · 435 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I Dose Escalation and Pharmacokinetic Study of Lapatinib in Combination With Trastuzumab in Patients With Advanced ErbB2-Positive Breast Cancer

Anna Maria Storniolo, Mark D. Pegram, Beth Overmoyer et al. · Journal of Clinical Oncology · 2008 · 119 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase I and Pharmacokinetic Study of Lapatinib in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Quincy S. Chu, Garry Schwartz, Johann S. de Bono et al. · Journal of Clinical Oncology · 2007 · 62 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A randomized and open-label trial evaluating the addition of pazopanib to lapatinib as first-line therapy in patients with HER2-positive advanced breast cancer

Stephen Johnston, Henry Gómez, Salomon M. Stemmer et al. · Breast Cancer Research and Treatment · 2013 · 45 citations

Medicine, Oncology, Pharmacology +14